Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip E Castle

Showing results (81-90 of 490) with videos related to

Pageof 49
Sort By:
The Journal of Infectious Diseases|October 17, 2006
Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancerCosette M Wheeler, William C Hunt, Mark Schiffman, et al.
Archives of Internal Medicine|May 30, 2012
Safety against cervical precancer and cancer following negative human papillomavirus and Papanicolaou test results in human immunodeficiency virus-infected womenPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Journal of Clinical Microbiology|December 14, 2011
Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancerMorgan A Marks, Philip E Castle, Mark Schiffman, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 8, 2011
Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage StudyNicole G Campos, Philip E Castle, Mark Schiffman, et al.
International Journal of Cancer|June 30, 2005
Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytologyPhilip E Castle, Joan L Walker, Mark Schiffman, et al.
The American Journal of Surgical Pathology|January 21, 2015
Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trialsAnne M Mills, Cherie Paquette, Philip E Castle, et al.
Journal of Clinical Microbiology|February 6, 2015
Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytologyPhilip E Castle, Barbara Eaton, Jennifer Reid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2017
Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical CancerEmily A Burger, Jane J Kim, Stephen Sy, et al.
Journal of Lower Genital Tract Disease|December 29, 2007
Risk assessment to guide the prevention of cervical cancerPhilip E Castle, Mario Sideri, Jose Jeronimo, et al.
International Journal of Cancer|July 24, 2009
How to evaluate emerging technologies in cervical cancer screening?Marc Arbyn, Guglielmo Ronco, Jack Cuzick, et al.
Pageof 49

Showing results (81-90 of 490) with videos related to

Sort By:
Pageof 49
The Journal of Infectious Diseases|October 17, 2006
Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancerCosette M Wheeler, William C Hunt, Mark Schiffman, et al.
Archives of Internal Medicine|May 30, 2012
Safety against cervical precancer and cancer following negative human papillomavirus and Papanicolaou test results in human immunodeficiency virus-infected womenPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Journal of Clinical Microbiology|December 14, 2011
Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancerMorgan A Marks, Philip E Castle, Mark Schiffman, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 8, 2011
Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage StudyNicole G Campos, Philip E Castle, Mark Schiffman, et al.
International Journal of Cancer|June 30, 2005
Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytologyPhilip E Castle, Joan L Walker, Mark Schiffman, et al.
The American Journal of Surgical Pathology|January 21, 2015
Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trialsAnne M Mills, Cherie Paquette, Philip E Castle, et al.
Journal of Clinical Microbiology|February 6, 2015
Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytologyPhilip E Castle, Barbara Eaton, Jennifer Reid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2017
Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical CancerEmily A Burger, Jane J Kim, Stephen Sy, et al.
Journal of Lower Genital Tract Disease|December 29, 2007
Risk assessment to guide the prevention of cervical cancerPhilip E Castle, Mario Sideri, Jose Jeronimo, et al.
International Journal of Cancer|July 24, 2009
How to evaluate emerging technologies in cervical cancer screening?Marc Arbyn, Guglielmo Ronco, Jack Cuzick, et al.
Pageof 49